一目了然——同时监测阿片类药物处方实践和阿片类相关死亡：加拿大新斯科舍省的背景。
At-a-glance - Concurrent monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova Scotia, Canada.
机构信息
Public Health Agency of Canada, Halifax, Nova Scotia, Canada.
Nova Scotia Prescription Monitoring Program, Dartmouth, Nova Scotia, Canada.
出版信息
Health Promot Chronic Dis Prev Can. 2018 Sep;38(9):334-338. doi: 10.24095/hpcdp.38.9.05.
Abstract
Timely public health surveillance is required to understand trends in opioid use and harms. Here, opioid dispensing data from the Nova Scotia Prescription Monitoring Program are presented alongside fatality data from the Nova Scotia Medical Examiner Service. Concurrent monitoring of trends in these data sources is essential to detect population-level effects (whether intended or unintended) of interventions related to opioid prescribing.
摘要
需要及时进行公共卫生监测，以了解阿片类药物使用和危害的趋势。在此，展示了来自新斯科舍省处方监测计划的阿片类药物配药数据，以及来自新斯科舍省法医服务的死亡数据。同时监测这些数据源中的趋势对于检测与阿片类药物处方相关的干预措施（无论是有意还是无意的）对人群产生的影响至关重要。
相似文献
1
At-a-glance - Concurrent monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova Scotia, Canada.
Health Promot Chronic Dis Prev Can. 2018 Sep;38(9):334-338. doi: 10.24095/hpcdp.38.9.05.
2
Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.
BMC Public Health. 2020 Jan 31;20(1):143. doi: 10.1186/s12889-020-8205-z.
3
Opioid Prescribing Patterns Before Fatal Opioid Overdose.
Am J Prev Med. 2020 Feb;58(2):250-253. doi: 10.1016/j.amepre.2019.09.022.
4
Suicide and drug toxicity mortality in the first year of the COVID-19 pandemic: use of medical examiner data for public health in Nova Scotia.
Health Promot Chronic Dis Prev Can. 2022 Feb 16;42(2):60-67. doi: 10.24095/hpcdp.42.2.02. Epub 2021 Nov 10.
5
Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013.
Aust N Z J Public Health. 2017 Feb;41(1):85-91. doi: 10.1111/1753-6405.12568. Epub 2016 Sep 13.
6
Location of fatal prescription opioid-related deaths in 12 states, 2008-2010: Implications for prevention programs.
J Safety Res. 2016 Sep;58:105-9. doi: 10.1016/j.jsr.2016.07.004. Epub 2016 Aug 7.
7
Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study.
BMC Clin Pharmacol. 2012 Jun 18;12:11. doi: 10.1186/1472-6904-12-11.
8
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
9
The source of methadone in overdose deaths in Western Virginia in 2004.
J Addict Med. 2011 Sep;5(3):188-202. doi: 10.1097/ADM.0b013e318211c56a.
10
Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.
CMAJ. 2016 Mar 1;188(4):E67-E72. doi: 10.1503/cmaj.150349. Epub 2015 Nov 30.
引用本文的文献
1
Impact of the COVID-19 pandemic on opioid toxicity mortality rates in Nova Scotia: An interrupted time series analysis (2009-2023).
Can J Public Health. 2025 Aug 6. doi: 10.17269/s41997-025-01092-8.
2
Problematic Opioid Use: A Scoping Literature Review of Profiles.
Subst Abuse. 2022 Jul 28;16:11782218221103581. doi: 10.1177/11782218221103581. eCollection 2022.
3
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province.
BMC Psychiatry. 2022 Jul 30;22(1):516. doi: 10.1186/s12888-022-04175-9.
4
Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness.
Drug Alcohol Depend. 2022 Jun 1;235:109440. doi: 10.1016/j.drugalcdep.2022.109440. Epub 2022 Apr 7.
5
Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis.
PLoS One. 2022 Jan 26;17(1):e0263156. doi: 10.1371/journal.pone.0263156. eCollection 2022.
6
Patterns, trends and determinants of medical opioid utilization in Canada 2005-2020: characterizing an era of intensive rise and fall.
Subst Abuse Treat Prev Policy. 2021 Sep 14;16(1):65. doi: 10.1186/s13011-021-00396-5.
7
Commentary - Broadening our understanding of Canada's epidemics of pharmaceutical and contaminated street drug opioid-related overdoses.
Health Promot Chronic Dis Prev Can. 2018 Sep;38(9):309-311. doi: 10.24095/hpcdp.38.9.01.
本文引用的文献
1
An emergency response to the opioid overdose crisis in Canada: a regulated opioid distribution program.
CMAJ. 2018 Jan 15;190(2):E35-E36. doi: 10.1503/cmaj.171060.
2
Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
Drug Alcohol Depend. 2018 Feb 1;183:1-6. doi: 10.1016/j.drugalcdep.2017.10.020. Epub 2017 Dec 6.
3
Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis.
CMAJ Open. 2017 Nov 22;5(4):E800-E807. doi: 10.9778/cmajo.20170104.
4
Ten Steps the Federal Government Should Take Now to Reverse the Opioid Addiction Epidemic.
JAMA. 2017 Oct 24;318(16):1537-1538. doi: 10.1001/jama.2017.14567.
5
Guideline for opioid therapy and chronic noncancer pain.
CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363.
6
Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1.
7
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.
CMAJ. 2016 Dec 6;188(17-18):1240-1244. doi: 10.1503/cmaj.160356. Epub 2016 Nov 7.
8
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
9
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.
N Engl J Med. 2016 Jan 14;374(2):154-63. doi: 10.1056/NEJMra1508490.
10
Harms of prescription opioid use in the United States.
Subst Abuse Treat Prev Policy. 2014 Oct 27;9:43. doi: 10.1186/1747-597X-9-43.
Zotero 插件